[{"from": "human", "value": "Provide a brief overview of this molecule. [C][C][/C][=Branch2][Ring2][Branch1][=C][Branch2][Ring1][C][/C][=C][C][=C][Branch1][Branch1][C][=C][Ring1][=Branch1][/C][=C][/C][=Branch1][C][=O][O][\\C][=C][C][=C][Branch1][Branch1][C][=C][Ring1][=Branch1][N][N][=C][Ring1][#Branch1][/C][=C][Branch1][#Branch2][C][=C][Branch1][Branch1][C][=C][Ring1][=Branch1][F][Cl]"}, {"from": "gpt", "value": "The molecule is an orally available, nonsteroidal selective estrogen receptor degrader (SERD), with potential antineoplastic activity. Upon oral administration, brilanestrant binds to the estrogen receptor and induces a conformational change that results in the degradation of the receptor. This may inhibit the growth and survival of ER-expressing cancer cells."}]